The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.
Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group
Sanofi and GSK have released positive data for their Beta vaccine to protect against COVID-19. ... adjuvant. Thomas Triomphe, executive vice president vaccines, Sanofi, said the “results reinforce the strong potential for the Beta antigen to confer
for Sanofi. Accelerated Virtual Consensus Programme: Multiple Sclerosis and the COVID-19 Vaccination. ... by Lucid Group. for Sanofi. MS in the 21st Century: ‘myMS’ Tools to Empower Patients in Shared-Care Decisions.
The US Food and Drug Administration (FDA) has accepted priority review of Sanofi and Regeneron’s jointly developed Dupixent (dupilumab) to treat adults with prurigo nodularis.
The National Institute for Health and Care Excellence (NICE) has recommended Sanofi and Regeneron’s Libtayo (cemiplimab) for patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC). ... Fleur Chandler, head of market access
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...